DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+28.73%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$2.68B
AUM Growth
+$2.68B
(+8.7%)
Cap. Flow
-$199M
Cap. Flow
% of AUM
-7.42%
Top 10 Holdings %
Top 10 Hldgs %
42.9%
Holding
149
New
19
Increased
23
Reduced
32
Closed
38
Top Buys
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$79.6M |
| 2 |
NVRO
NEVRO CORP.
NVRO
|
$40.5M |
| 3 |
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
|
$35.8M |
| 4 |
Vanda Pharmaceuticals
VNDA
|
$28.2M |
| 5 |
AGN
ALLERGAN INC
AGN
|
$24.5M |
Top Sells
| 1 |
KITE
Kite Pharma, Inc.
KITE
|
$49.4M |
| 2 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$46M |
| 3 |
AbbVie
ABBV
|
$44.3M |
| 4 |
BLUE
bluebird bio
BLUE
|
$37.4M |
| 5 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
$30.9M |
Sector Composition
| 1 | Healthcare | 54.5% |
| 2 | Financials | 2.8% |
| 3 | Technology | 0.75% |
| 4 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBST
26
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $21.2M | 0.76% |
+210,200
| New | +$21.2M |
|
|
ATRS
27
DELISTED
Antares Pharma, Inc.
ATRS
| $20.8M | 0.75% |
8,104,318
+280,700
| +4% | +$721K |
|
28
McKesson
MCK
$85.9B
| $19.1M | 0.69% |
92,000
-30,000
| -25% | -$6.23M |
|
|
JUNO
29
DELISTED
Juno Therapeutics, Inc.
JUNO
| $18.7M | 0.67% |
+358,149
| New | +$18.7M |
|
|
LOXO
30
DELISTED
Loxo Oncology, Inc
LOXO
| $18.7M | 0.67% |
1,591,546
| – | – |
|
|
PTLA
31
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $18.6M | 0.67% |
655,559
+98,082
| +18% | +$2.78M |
|
32
Trupanion
TRUP
$1.9B
| $18.6M | 0.67% |
2,678,176
+1,222,799
| +84% | +$8.47M |
|
|
KERX
33
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $16.7M | 0.6% |
1,183,484
-50,000
| -4% | -$707K |
|
34
ResMed
RMD
$39.4B
| $16.6M | 0.6% |
+296,300
| New | +$16.6M |
|
35
Orthofix Medical
OFIX
$583M
| $16M | 0.58% |
533,812
| – | – |
|
36
Amphastar Pharmaceuticals
AMPH
$1.37B
| $14.8M | 0.53% |
1,276,577
-138,498
| -10% | -$1.61M |
|
|
TRIV
37
DELISTED
TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK
TRIV
| $14.4M | 0.52% |
1,148,575
-383,956
| -25% | -$4.83M |
|
38
Accuray
ARAY
$165M
| $14.1M | 0.51% |
+1,870,943
| New | +$14.1M |
|
|
DYAX
39
DELISTED
DYAX CORPORATION
DYAX
| $13.8M | 0.5% |
982,745
-1,971,939
| -67% | -$27.7M |
|
|
IMMU
40
DELISTED
Immunomedics Inc
IMMU
| $13.5M | 0.48% |
2,805,972
| – | – |
|
41
Protara Therapeutics
TARA
$125M
| $13.2M | 0.47% |
+31,634
| New | +$13.2M |
|
|
DBVT
42
DBV Technologies
DBVT
$249M
| $13.1M | 0.47% |
+48,230
| New | +$13.1M |
|
|
IMPR
43
DELISTED
IMPRIVATA, INC COM
IMPR
| $13M | 0.47% |
998,252
+27,301
| +3% | +$355K |
|
|
NSTG
44
DELISTED
NanoString Technologies, Inc.
NSTG
| $12.9M | 0.46% |
923,378
-80,596
| -8% | -$1.12M |
|
45
MEI Pharma
MEIP
$149M
| $12.6M | 0.45% |
146,994
+96,404
| +191% | +$8.23M |
|
|
HTWR
46
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| $12.1M | 0.43% |
+164,800
| New | +$12.1M |
|
47
Inogen
INGN
$213M
| $11.1M | 0.4% |
354,330
-198,007
| -36% | -$6.21M |
|
|
SAGE
48
DELISTED
Sage Therapeutics
SAGE
| $9.61M | 0.35% |
262,625
-188,042
| -42% | -$6.88M |
|
|
ICPT
49
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $9.42M | 0.34% |
60,393
-38,300
| -39% | -$5.97M |
|
|
KITE
50
DELISTED
Kite Pharma, Inc.
KITE
| $8.99M | 0.32% |
155,799
-856,199
| -85% | -$49.4M |
|